The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garza, H. H.
Right arrow Articles by Carr, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garza, H. H., Jr
Right arrow Articles by Carr, D. J.

The Journal of Immunology, Vol 156, Issue 10 3631-3637, Copyright © 1996 by American Association of Immunologists


ARTICLES

Aberrant regulation of cytokines in HIV-1 TAT72-transgenic mice

HH Garza Jr, O Prakash and DJ Carr
Department of Microbiology, Immunology, and Parasitology, Louisiana State University Medical Center, New Orleans 70112, USA.

The trans-activator of transcription or TAT gene from HIV-1 encodes a protein that increases the processivity of transcription from the HIV-1 genome. TAT protein can also affect cellular processes in the absence of its ribonucleic HIV target sequence trans activation response element and may be responsible for some aspects of HIV pathogenesis apart from infectious virus or other viral gene products. We have previously shown that TAT72 decreases CTL activity in TAT72-transgenic mice, and we now demonstrate aberrant regulation of mitogen-elicited IL- 2 at both transcriptional and translational levels. In contrast, alloantigen stimulation resulted in increased IL-6 and IL-10 production in the TAT72-transgenic mice. Con A-stimulated cultures of splenic lymphocytes from TAT72-transgenic mice do not undergo clonal proliferation of CD4+ cells as compared with CD8+ cells monitored over 72 h. These results suggest that TAT is sufficient to induce some pathology associated with AIDS and is a potent immunologic manipulator apart from its function as trans-activator.


This article has been cited by other articles:


Home page
J. Immunol.Home page
H. K. Avraham, S. Jiang, T.-H. Lee, O. Prakash, and S. Avraham
HIV-1 Tat-Mediated Effects on Focal Adhesion Assembly and Permeability in Brain Microvascular Endothelial Cells
J. Immunol., November 15, 2004; 173(10): 6228 - 6233.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. O. Kim, Y. Liu, Y. Ruan, Z. C. Xu, L. Schantz, and J. J. He
Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline
Am. J. Pathol., May 1, 2003; 162(5): 1693 - 1707.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. Raidel, C. Haase, N. R. Jansen, R. B. Russ, R. L. Sutliff, L. W. Velsor, B. J. Day, B. D. Hoit, A. M. Samarel, and W. Lewis
Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage
Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1672 - H1678.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Secchiero, D. Zella, S. Curreli, P. Mirandola, S. Capitani, R. C. Gallo, and G. Zauli
Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication
PNAS, December 8, 2000; (2000) 11512398.
[Abstract] [Full Text]


Home page
J Natl Cancer Inst MonogrHome page
F. Samaniego, S. Pati, J. E. Karp, O. Prakash, and D. Bose
Human Herpesvirus 8 K1-Associated Nuclear Factor-kappa B-Dependent Promoter Activity: Role in Kaposi's Sarcoma Inflammation?
J Natl Cancer Inst Monographs, December 1, 2000; 2000(28): 15 - 23.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
O. Prakash, Z.-Y. Tang, Y.-e He, M. S. Ali, R. Coleman, J. Gill, G. Farr, and F. Samaniego
Human Kaposi's Sarcoma Cell-Mediated Tumorigenesis in Human Immunodeficiency Type 1 Tat-Expressing Transgenic Mice
J Natl Cancer Inst, May 3, 2000; 92(9): 721 - 728.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Mitola, R. Soldi, I. Zanon, L. Barra, M. I. Gutierrez, B. Berkhout, M. Giacca, and F. Bussolino
Identification of Specific Molecular Structures of Human Immunodeficiency Virus Type 1 Tat Relevant for Its Biological Effects on Vascular Endothelial Cells
J. Virol., January 1, 2000; 74(1): 344 - 353.
[Abstract] [Full Text]


Home page
BloodHome page
R. K. Kundu, F. Sangiorgi, L.-Y. Wu, P. K. Pattengale, D. R. Hinton, P. S. Gill, and R. Maxson
Expression of the Human Immunodeficiency Virus-Tat Gene in Lymphoid Tissues of Transgenic Mice Is Associated With B-Cell Lymphoma
Blood, July 1, 1999; 94(1): 275 - 282.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Secchiero, D. Zella, S. Curreli, P. Mirandola, S. Capitani, R. C. Gallo, and G. Zauli
Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication
PNAS, December 19, 2000; 97(26): 14620 - 14625.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.